These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 35172264)
21. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production. Cotzomi E; Stathopoulos P; Lee CS; Ritchie AM; Soltys JN; Delmotte FR; Oe T; Sng J; Jiang R; Ma AK; Vander Heiden JA; Kleinstein SH; Levy M; Bennett JL; Meffre E; O'Connor KC Brain; 2019 Jun; 142(6):1598-1615. PubMed ID: 31056665 [TBL] [Abstract][Full Text] [Related]
22. Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder. Tradtrantip L; Yeaman MR; Verkman AS Sci Rep; 2021 Nov; 11(1):21962. PubMed ID: 34753987 [TBL] [Abstract][Full Text] [Related]
23. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Tao S; Zhang Y; Ye H; Guo D Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657 [TBL] [Abstract][Full Text] [Related]
24. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies. Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C Front Immunol; 2021; 12():647618. PubMed ID: 33796113 [No Abstract] [Full Text] [Related]
25. Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder. Fung S; Shirley M CNS Drugs; 2023 Apr; 37(4):363-370. PubMed ID: 36933107 [TBL] [Abstract][Full Text] [Related]
27. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature. Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992 [TBL] [Abstract][Full Text] [Related]
28. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies. Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529 [TBL] [Abstract][Full Text] [Related]
29. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study. Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457 [TBL] [Abstract][Full Text] [Related]
30. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591 [TBL] [Abstract][Full Text] [Related]
31. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines. Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205 [TBL] [Abstract][Full Text] [Related]
32. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort. Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910 [TBL] [Abstract][Full Text] [Related]
33. Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa. Wang J; Wang J; Xie W; Liu J; Feng J; Wei W; Li M; Wu L; Wang C; Li R Int Immunopharmacol; 2023 Mar; 116():109761. PubMed ID: 36709595 [TBL] [Abstract][Full Text] [Related]
34. Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder. Yuan C; Liu X; Cai S; Zhang L; Guo R; Jia Z; Sun Y; Li B Mult Scler Relat Disord; 2023 Feb; 70():104504. PubMed ID: 36623394 [TBL] [Abstract][Full Text] [Related]
36. The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder. Chen B; Qin C; Tao R; Dong YJ; Ma X; Chen M; Wu LJ; Bu BT; Tian DS Mult Scler Relat Disord; 2020 Feb; 38():101880. PubMed ID: 31812873 [TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
38. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963 [TBL] [Abstract][Full Text] [Related]
39. Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS. Gao C; Su L; Li H; Song T; Liu Y; Duan Y; Shi FD Mult Scler Relat Disord; 2024 Feb; 82():105406. PubMed ID: 38176283 [TBL] [Abstract][Full Text] [Related]
40. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies. Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]